Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-08-000016

Options or other derivatives

  • Director acquired 15,000 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

SOBEL BURTON E · Director

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2008-06-04 Grant or award : show line 1 in the form Non-Qualified Stock Option (right to buy) +15,000 $0.73 2018-06-03 15,000 15,000 D
Loading xslF345X02/edgar.xml…